News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
190,301 Results
Type
Article (18190)
Company Profile (126)
Press Release (171978)
Multimedia
Podcasts (42)
Webinars (12)
Section
Business (58951)
Career Advice (953)
Deals (9524)
Drug Delivery (38)
Drug Development (23655)
Employer Resources (72)
FDA (2451)
Job Trends (4320)
News (93420)
Policy (5904)
Tag
Academia (493)
Accelerated approval (7)
Adcomms (15)
Allergies (28)
Alliances (16445)
ALS (54)
Alzheimer's disease (524)
Antibody-drug conjugate (ADC) (118)
Approvals (2406)
Artificial intelligence (156)
Autoimmune disease (29)
Automation (9)
Bankruptcy (83)
Best Places to Work (2919)
BIOSECURE Act (19)
Biosimilars (45)
Biotechnology (114)
Bladder cancer (53)
Brain cancer (17)
Breast cancer (149)
Cancer (1387)
Cardiovascular disease (102)
Career advice (777)
Career pathing (21)
CAR-T (137)
CDC (4)
Cell therapy (363)
Cervical cancer (10)
Clinical research (19564)
Collaboration (625)
Company closure (3)
Compensation (197)
Complete response letters (21)
COVID-19 (769)
CRISPR (37)
C-suite (290)
Cystic fibrosis (51)
Data (1383)
Denatured (6)
Depression (34)
Diabetes (96)
Diagnostics (1119)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (21)
Drug discovery (94)
Drug pricing (33)
Drug shortages (2)
Duchenne muscular dystrophy (89)
Earnings (16813)
Editorial (20)
Employer branding (8)
Employer resources (69)
Events (32763)
Executive appointments (492)
FDA (3056)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (7)
Funding (532)
Gene editing (83)
Generative AI (15)
Gene therapy (277)
GLP-1 (322)
Government (688)
Grass and pollen (1)
Guidances (76)
Healthcare (2471)
HIV (8)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (121)
Immuno-oncology (14)
Indications (15)
Infectious disease (845)
Inflammatory bowel disease (88)
Inflation Reduction Act (3)
Influenza (30)
Intellectual property (67)
Interviews (141)
IPO (4191)
IRA (14)
Job creations (1483)
Job search strategy (706)
Kidney cancer (7)
Labor market (43)
Layoffs (221)
Leadership (20)
Legal (1218)
Liver cancer (23)
Longevity (5)
Lung cancer (168)
Lymphoma (130)
Machine learning (10)
Management (23)
Manufacturing (258)
MASH (43)
Medical device (736)
Medtech (737)
Mergers & acquisitions (5665)
Metabolic disorders (338)
Multiple sclerosis (50)
NASH (8)
Neurodegenerative disease (88)
Neuropsychiatric disorders (20)
Neuroscience (887)
NextGen: Class of 2025 (1488)
Non-profit (497)
Now hiring (29)
Obesity (180)
Opinion (187)
Ovarian cancer (50)
Pain (47)
Pancreatic cancer (56)
Parkinson's disease (85)
Partnered (11)
Patents (138)
Patient recruitment (103)
Peanut (16)
People (22843)
Pharmaceutical (16)
Phase I (7557)
Phase II (9364)
Phase III (5234)
Pipeline (947)
Policy (105)
Postmarket research (307)
Preclinical (3116)
Press Release (63)
Prostate cancer (48)
Psychedelics (23)
Radiopharmaceuticals (87)
Rare diseases (265)
Real estate (2470)
Recruiting (36)
Regulatory (4921)
Reports (23)
Research institute (534)
Resumes & cover letters (153)
Rett syndrome (5)
RNA editing (12)
RSV (18)
Schizophrenia (31)
Series A (111)
Series B (78)
Service/supplier (6)
Sickle cell disease (27)
Special edition (14)
Spinal muscular atrophy (50)
Sponsored (14)
Startups (1813)
State (1)
Stomach cancer (6)
Supply chain (29)
Tariffs (31)
The Weekly (36)
Vaccines (298)
Venture capital (55)
Weight loss (113)
Women's health (11)
Worklife (8)
Date
Today (19)
Last 7 days (195)
Last 30 days (837)
Last 365 days (12011)
2025 (8398)
2024 (12751)
2023 (13342)
2022 (16151)
2021 (17029)
2020 (13265)
2019 (9687)
2018 (7718)
2017 (9037)
2016 (8194)
2015 (9492)
2014 (9758)
2013 (9496)
2012 (6126)
2011 (6505)
2010 (5885)
Location
Africa (334)
Alabama (44)
Alaska (3)
Arizona (59)
Arkansas (2)
Asia (14285)
Australia (2737)
California (3287)
Canada (963)
China (346)
Colorado (56)
Connecticut (124)
Delaware (68)
Europe (31182)
Florida (384)
Georgia (54)
Hawaii (2)
Idaho (13)
Illinois (179)
India (16)
Indiana (156)
Iowa (5)
Japan (106)
Kansas (19)
Kentucky (5)
Louisiana (5)
Maine (2)
Maryland (444)
Massachusetts (2511)
Michigan (95)
Minnesota (158)
Mississippi (1)
Missouri (22)
Montana (8)
Nebraska (4)
Nevada (21)
New Hampshire (7)
New Jersey (782)
New Mexico (11)
New York (811)
North Carolina (490)
North Dakota (6)
Northern California (1452)
Ohio (72)
Oklahoma (8)
Oregon (9)
Pennsylvania (626)
Puerto Rico (5)
Rhode Island (14)
South America (407)
South Carolina (3)
Southern California (1315)
Tennessee (24)
Texas (425)
United States (11016)
Utah (44)
Virginia (30)
Washington D.C. (19)
Washington State (431)
West Virginia (1)
Wisconsin (20)
190,301 Results for "nanjing legend biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
August 27, 2025
·
1 min read
Press Releases
Legend Biotech Appoints Carlos Santos as Chief Financial Officer
August 19, 2025
·
5 min read
Press Releases
Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights
August 12, 2025
·
16 min read
Press Releases
Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results
July 29, 2025
·
1 min read
Manufacturing
J&J, Legend Pump $150M Into Manufacturing in Bid to Double Carvykti Production
Johnson & Johnson and Legend Biotech hope to hit blockbuster status for Carvykti this year.
March 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Legend Biotech Reports First Quarter 2025 Results and Recent Highlights
May 14, 2025
·
15 min read
Press Releases
Legend Biotech to Host Investor Conference Call on First Quarter 2025 Results
April 30, 2025
·
1 min read
Press Releases
Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT
May 23, 2025
·
31 min read
Press Releases
Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
May 20, 2025
·
1 min read
Press Releases
Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting
June 4, 2025
·
35 min read
1 of 19,031
Next
